Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

CXC962

Cervical cancer and normal tissue array, non-overlapping with CXC961, 48 cases/96 cores
Unstained: $170.00 Add to Cart
H&E (CXC962s*): $170.00 Add to Cart

Microarray Panel:Cervical cancer tissue microarray, non-overlapping with CXC961, 96 cores including 36 cases (purple/blue) of cervix cancers and 12 cases of normal and inflammatory tissues of the cervix in duplicates. Each slide has ~95% tissue core retention
Cores:96
Cases:48
Layout:12 cols × 8 rows
Core Diameter:1.5 mm
Thickness:4 µm
Quality Control:H&E, IHC anti-Cytokeratin
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade TNM Type †
A1 1 F 34 cervix Normal Malignant
A2 2 F 41 cervix Normal Malignant
A3 3 F 44 cervix Normal Malignant
A4 4 F 44 cervix Normal Malignant
A5 5 F 47 cervix Polyps Malignant
A6 6 F 43 cervix Polyps Malignant
A7 7 F 49 cervix Chronic cervicitis Malignant
A8 8 F 69 cervix Chronic cervicitis Malignant
A9 9 F 44 cervix Chronic cervicitis Malignant
A10 10 F 34 cervix Carcinoma in situ* TisN0M0 Malignant
A11 11 F 50 cervix Carcinoma in situ* TisN0M0 Malignant
A12 12 F 30 cervix Carcinoma in situ* TisN0M0 Malignant
B1 13 F 34 cervix Normal Malignant
B2 14 F 41 cervix Normal Malignant
B3 15 F 44 cervix Normal Malignant
B4 16 F 44 cervix Normal Malignant
B5 17 F 47 cervix Polyps Malignant
B6 18 F 43 cervix Polyps Malignant
B7 19 F 49 cervix Chronic cervicitis Malignant
B8 20 F 69 cervix Chronic cervicitis Malignant
B9 21 F 44 cervix Chronic cervicitis Malignant
B10 22 F 34 cervix Carcinoma in situ* TisN0M0 Malignant
B11 23 F 50 cervix Carcinoma in situ* TisN0M0 Malignant
B12 24 F 30 cervix Carcinoma in situ* TisN0M0 Malignant
C1 25 F 32 cervix Squamous cell carcinoma I~II T1N0M0 Malignant
C2 26 F 59 cervix Squamous cell carcinoma II T1N0M0 Malignant
C3 27 F 56 cervix Squamous cell carcinoma II T1N0M0 Malignant
C4 28 F 46 cervix Squamous cell carcinoma II T1N0M0 Malignant
C5 29 F 44 cervix Squamous cell carcinoma II T2N1M0 Malignant
C6 30 F 43 cervix Squamous cell carcinoma II T1N1M0 Malignant
C7 31 F 63 cervix Squamous cell carcinoma II T1N0M0 Malignant
C8 32 F 44 cervix Squamous cell carcinoma II T1N0M0 Malignant
C9 33 F 50 cervix Squamous cell carcinoma II T1N1M0 Malignant
C10 34 F 55 cervix Squamous cell carcinoma II T1N0M0 Malignant
C11 35 F 67 cervix Squamous cell carcinoma II T1N0M0 Malignant
C12 36 F 38 cervix Squamous cell carcinoma II T1N0M0 Malignant
D1 37 F 32 cervix Squamous cell carcinoma I~II T1N0M0 Malignant
D2 38 F 59 cervix Squamous cell carcinoma II T1N0M0 Malignant
D3 39 F 56 cervix Squamous cell carcinoma II T1N0M0 Malignant
D4 40 F 46 cervix Squamous cell carcinoma II T1N0M0 Malignant
D5 41 F 44 cervix Squamous cell carcinoma II T2N1M0 Malignant
D6 42 F 43 cervix Squamous cell carcinoma II T1N1M0 Malignant
D7 43 F 63 cervix Squamous cell carcinoma II T1N0M0 Malignant
D8 44 F 44 cervix Squamous cell carcinoma II T1N0M0 Malignant
D9 45 F 50 cervix Squamous cell carcinoma II T1N1M0 Malignant
D10 46 F 55 cervix Squamous cell carcinoma II T1N0M0 Malignant
D11 47 F 67 cervix Squamous cell carcinoma II T1N0M0 Malignant
D12 48 F 38 cervix Squamous cell carcinoma II T1N0M0 Malignant
E1 49 F 52 cervix Squamous cell carcinoma II T1N0M0 Malignant
E2 50 F 42 cervix Squamous cell carcinoma II T1N0M0 Malignant
E3 51 F 34 cervix Squamous cell carcinoma II T1N0M0 Malignant
E4 52 F 70 cervix Squamous cell carcinoma II~III T1N0M0 Malignant
E5 53 F 43 cervix Squamous cell carcinoma II~III T1N0M0 Malignant
E6 54 F 28 cervix Squamous cell carcinoma II~III T2N0M0 Malignant
E7 55 F 31 cervix Squamous cell carcinoma II~III T1N0M0 Malignant
E8 56 F 31 cervix Squamous cell carcinoma II~III T2N0M0 Malignant
E9 57 F 26 cervix Squamous cell carcinoma II~III T1N0M0 Malignant
E10 58 F 53 cervix Squamous cell carcinoma II~III T1N0M0 Malignant
E11 59 F 34 cervix Squamous cell carcinoma II~III T1N0M0 Malignant
E12 60 F 50 cervix Squamous cell carcinoma II~III T1N0M0 Malignant
F1 61 F 52 cervix Squamous cell carcinoma II T1N0M0 Malignant
F2 62 F 42 cervix Squamous cell carcinoma II T1N0M0 Malignant
F3 63 F 34 cervix Squamous cell carcinoma II T1N0M0 Malignant
F4 64 F 70 cervix Squamous cell carcinoma II~III T1N0M0 Malignant
F5 65 F 43 cervix Squamous cell carcinoma II~III T1N0M0 Malignant
F6 66 F 28 cervix Squamous cell carcinoma II~III T2N0M0 Malignant
F7 67 F 31 cervix Squamous cell carcinoma II~III T1N0M0 Malignant
F8 68 F 31 cervix Squamous cell carcinoma II~III T2N0M0 Malignant
F9 69 F 26 cervix Squamous cell carcinoma II~III T1N0M0 Malignant
F10 70 F 53 cervix Squamous cell carcinoma II~III T1N0M0 Malignant
F11 71 F 34 cervix Squamous cell carcinoma II~III T1N0M0 Malignant
F12 72 F 50 cervix Squamous cell carcinoma II~III T1N0M0 Malignant
G1 73 F 52 cervix Squamous cell carcinoma III T1N0M0 Malignant
G2 74 F 31 cervix Squamous cell carcinoma III T2N1M0 Malignant
G3 75 F 53 cervix Squamous cell carcinoma III T1N1M0 Malignant
G4 76 F 22 cervix Squamous cell carcinoma III T2N0M0 Malignant
G5 77 F 40 cervix Squamous cell carcinoma III T1N0M0 Malignant
G6 78 F 44 cervix Squamous cell carcinoma III T1N0M0 Malignant
G7 79 F 48 cervix Undifferentiated cacinoma III T1N0M0 Malignant
G8 80 F 52 cervix Undifferentiated cacinoma III T1N0M0 Malignant
G9 81 F 27 cervix Adenosquamous carcinoma T2N1M0 Malignant
G10 82 F 33 cervix Adenosquamous carcinoma T1N0M0 Malignant
G11 83 F 24 cervix Adenocarcinoma II~III T1N0M0 Malignant
G12 84 F 54 cervix Metastases from ovarian carcinoma Metastasis
H1 85 F 52 cervix Squamous cell carcinoma III T1N0M0 Malignant
H2 86 F 31 cervix Squamous cell carcinoma III T2N1M0 Malignant
H3 87 F 53 cervix Squamous cell carcinoma III T1N1M0 Malignant
H4 88 F 22 cervix Squamous cell carcinoma III T2N0M0 Malignant
H5 89 F 40 cervix Squamous cell carcinoma III T1N0M0 Malignant
H6 90 F 44 cervix Squamous cell carcinoma III T1N0M0 Malignant
H7 91 F 48 cervix Undifferentiated cacinoma III T1N0M0 Malignant
H8 92 F 52 cervix Undifferentiated cacinoma III T1N0M0 Malignant
H9 93 F 27 cervix Adenosquamous carcinoma T2N1M0 Malignant
H10 94 F 33 cervix Adenosquamous carcinoma T1N0M0 Malignant
H11 95 F 24 cervix Adenocarcinoma II~III T1N0M0 Malignant
H12 96 F 54 cervix Metastases from ovarian carcinoma Metastasis


† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Sorry, this tissue array cannot be compared to find overlapping cases.
© 2003 - 2011 US Biomax Inc., custsrv@biomax.us, Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal